Skip to main content
. 2022 Sep 2;71(35):1101–1108. doi: 10.15585/mmwr.mm7135a1

FIGURE 2.

The figure consists of three line charts showing coverage with ≥1 dose of human papillomavirus vaccine (panel A), ≥1 dose of quadrivalent meningococcal conjugate vaccine (panel B), and ≥1 dose of tetanus, diphtheria, and acellular pertussis vaccine (panel C), among adolescents in the 2002–2008 annual birth cohorts in the United States, by birth year and milestone age using data from the National Immunization Survey-Teen during 2015–2021.

Coverage with ≥1 dose of human papillomavirus vaccine (A), ≥1 dose of quadrivalent meningococcal conjugate vaccine (B), and ≥1 dose of tetanus, diphtheria, and acellular pertussis vaccine (C), among adolescents in the 2002–2008 annual birth cohorts, by birth year and milestone age* — National Immunization Survey-Teen, United States, 2015–2021

Abbreviations: HPV = human papillomavirus; MenACWY = quadrivalent meningococcal conjugate vaccine; Tdap = tetanus, diphtheria, and acellular pertussis vaccine.

* Milestone age is the age in years by which the cumulative percent of adolescents vaccinated was assessed and represents vaccination status up to but not including the birthday by which adolescents reached the indicated age.